<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02459496</url>
  </required_header>
  <id_info>
    <org_study_id>DiNA-D</org_study_id>
    <nct_id>NCT02459496</nct_id>
  </id_info>
  <brief_title>Diabetes Nutrition Algorithms in Patients With Overt Diabetes Mellitus</brief_title>
  <acronym>DiNA-D</acronym>
  <official_title>Dietary Strategies to Improve Metabolism and Body Weight in Type 2 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>German Institute of Human Nutrition</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German Center for Diabetes Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>California Walnut Corporation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institute for Cereal Processing GmbH/Institut f√ºr Getreideverarbeitung (IGV)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>German Institute of Human Nutrition</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Basic treatment of type 2 diabetes should focus on diet, physical activity and lifestyle.
      Nevertheless, in early and late stage of T2DM, lifestyle intervention is mostly substituted
      by pharmacological intervention, although lifestyle modification and dietary treatment would
      be favourable.

      The researchers therefore investigate dietary strategies such as low-carb and very-low calory
      diets regarding their potential to improve metabolism and body weight in (mostly) long-term
      T2DM patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Basic treatment of type 2 diabetes should focus on diet, physical activity and lifestyle.
      Nevertheless, in early and late stage of T2DM, lifestyle intervention is mostly substituted
      by pharmacological intervention, although lifestyle modification and dietary treatment would
      be favourable.

      The researchers therefore investigate dietary strategies such as low-carb diets and very-low
      calory diets regarding their potential to improve metabolism and body weight in (mostly)
      long-term T2DM patients.

      An intensive intervention of 3 weeks is followed by an 11-month maintenance phase to
      consolidate metabolic improvements.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in insulin secretion (glucagon stimulation test)</measure>
    <time_frame>3 weeks, 1 year</time_frame>
    <description>change in insulin secretion (glucagon stimulation test)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in hepatic fat content (MR-S)</measure>
    <time_frame>3 weeks, 1 year</time_frame>
    <description>change in hepatic fat content (MR-S)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in insulin secretion in the mixed-meal tolerance test (MMTT) - combined parameter</measure>
    <time_frame>3 weeks, 1 year</time_frame>
    <description>change in insulin secretion in the mixed-meal tolerance test (MMTT) - combined parameter</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in insulin sensitivity in the mixed-meal tolerance test (MMTT) - combined parameter</measure>
    <time_frame>3 weeks, 1 year</time_frame>
    <description>change in insulin sensitivity in the mixed-meal tolerance test (MMTT) - combined parameter</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in blood glucose profile in the mixed-meal tolerance test (MMTT) - combined parameter</measure>
    <time_frame>3 weeks, 1 year</time_frame>
    <description>change in blood glucose profile in the mixed-meal tolerance test (MMTT) - combined parameter</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>inflammatory reaction in subcutaneous adipose tissue (SCAT analysis on protein and RNA level - IL-1; IL1beta, IL-6)</measure>
    <time_frame>3 weeks, 1 year</time_frame>
    <description>inflammatory reaction in subcutaneous adipose tissue (SCAT analysis on protein and RNA level)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in parameters of peripheral - vibration threshold, thermal sensitivity and pain thresholds</measure>
    <time_frame>3 weeks, 1 year</time_frame>
    <description>peripheral neuropathy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in parameters of autonomic neuropathy - measures of cardio-autonomic neuropathy (SANN, MSDD)</measure>
    <time_frame>3 weeks, 1 year</time_frame>
    <description>autonomic neuropathy</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Type 2 Diabetes</condition>
  <condition>NAFLD</condition>
  <condition>Obesity</condition>
  <condition>Dyslipoproteinaemia</condition>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>low-carb diet, followed by conventional DGE diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>subjects receive dietary consulting for a first phase of 3 weeks, being represented by a very-low calory low-carb ketogenic diet (VLCKD, below 40 g carbs per day), followed by an isocaloric or moderate hypocaloric low-carb diet (below 40 kcal% carbs per day)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>very-low calory diet, followed by conventional diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>subjects receive dietary consulting for a first phase of 3 weeks, being represented by a very-low calory diet (VLCD; MODIFAST substitute, approx. 1200 kcal/day), followed by a conventional isocaloric or moderate hypocaloric diet under DGE guidelines</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>dietary consulting and advise</intervention_name>
    <description>first phase: 3 weeks of very-low calory diet (low-carb or normo-carb) second phase: 49 weeks of eucaloric diet under DGE guidelines</description>
    <arm_group_label>low-carb diet, followed by conventional DGE diet</arm_group_label>
    <arm_group_label>very-low calory diet, followed by conventional diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male and female subjects

          -  18-79 years old

          -  type 2 diabetes

        Exclusion Criteria:

          -  renal insufficiency

          -  anaemia

          -  immunosuppression

          -  previous symptomatic cancer diagnosis

          -  acute cardiovascular disease (stroke, coronary syndrome)

          -  pregnancy and lactation

          -  severe psychiatric disorders

          -  corticoid or other immunosuppressive therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas F.H. Pfeiffer, Prof. Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>German Institute of Human Nutrition</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stefan Kabisch, Dr. med.</last_name>
    <phone>030 450 514</phone>
    <phone_ext>429</phone_ext>
    <email>stefan.kabisch@dife.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>June Inderthal</last_name>
    <phone>033 200 88 2771</phone>
    <email>june.inderthal@dife.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>German Institut for Human Nutrition; Department for Clinical Nutrition</name>
      <address>
        <city>Nuthetal</city>
        <state>Brandenburg</state>
        <zip>14458</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Margrit Kemper, Dr. med.</last_name>
      <phone>033200 88 2775</phone>
      <email>margrit.kemper@dife.de</email>
    </contact>
    <contact_backup>
      <last_name>Silke Hornemann</last_name>
      <phone>033200 88 2779</phone>
      <email>silke.hornemann@dife.de</email>
    </contact_backup>
    <investigator>
      <last_name>Margrit Kemper, Dr. med.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Silke Hornemann</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christiana Gerbracht, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>German Institute for Human Nutrition, Department for Clinical Nutrition</name>
      <address>
        <city>Berlin</city>
        <zip>12203</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Kabisch, Dr. med.</last_name>
      <phone>030 450 514</phone>
      <phone_ext>429</phone_ext>
      <email>stefan.kabisch@charite.de</email>
    </contact>
    <contact_backup>
      <last_name>Ulrike Kaiser, M.sc.</last_name>
      <phone>030 450 514</phone>
      <phone_ext>428</phone_ext>
      <email>ulrike.kaiser@charite.de</email>
    </contact_backup>
    <investigator>
      <last_name>Stefan Kabisch, Dr. med.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ulrike Kaiser, M.sc.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 23, 2015</study_first_submitted>
  <study_first_submitted_qc>May 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 2, 2015</study_first_posted>
  <last_update_submitted>November 21, 2016</last_update_submitted>
  <last_update_submitted_qc>November 21, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>German Institute of Human Nutrition</investigator_affiliation>
    <investigator_full_name>Prof. Dr. med. Andreas F. H. Pfeiffer</investigator_full_name>
    <investigator_title>Director of the Department for Clinical Nutrition</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Dyslipidemias</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

